Cite
MLA Citation
Andrew Stone and Nicola Schmitt. “Can a treatment be licenced on the basis of post‐treatment predictive biomarkers?.” Pharmaceutical statistics, vol. 13, n.d., pp. 214–221. http://access.bl.uk/ark:/81055/vdc_100024871675.0x000020